Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property

Aayushi Pandey, Rohit Bhawale, Ravindra Vasave, Omar Khan, Sri Pada Datta Chigurupati, Nalla Usha Kumari, Kshitiz Luthra, Neelesh Kumar Mehra

Open source

DOI
10.1021/acsabm.6c00351
Published
2026-04-27
Container
ACS Applied Bio Materials
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsabm.6c00351,
  title = {Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property},
  author = {Aayushi Pandey and Rohit Bhawale and Ravindra Vasave and Omar Khan and Sri Pada Datta Chigurupati and Nalla Usha Kumari and Kshitiz Luthra and Neelesh Kumar Mehra},
  year = {2026},
  journal = {ACS Applied Bio Materials},
  doi = {10.1021/acsabm.6c00351},
  url = {https://doi.org/10.1021/acsabm.6c00351}
}

RIS

TY  - JOUR
TI  - Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property
AU  - Aayushi Pandey
AU  - Rohit Bhawale
AU  - Ravindra Vasave
AU  - Omar Khan
AU  - Sri Pada Datta Chigurupati
AU  - Nalla Usha Kumari
AU  - Kshitiz Luthra
AU  - Neelesh Kumar Mehra
PY  - 2026
JO  - ACS Applied Bio Materials
DO  - 10.1021/acsabm.6c00351
UR  - https://doi.org/10.1021/acsabm.6c00351
ER  - 

APA

Pandey, A., Bhawale, R., Vasave, R., Khan, O., Chigurupati, S. P. D., Kumari, N. U., Luthra, K., & Mehra, N. K. (2026). Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00351

Source records